Stacie L. Daugherty, MD, MSPH
Medical Director of Clinical Trials | Senior Clinician Investigator
Stacie L. Daugherty, MD, MSPH, is the Medical Director of Clinical Trials and a Senior Clinician Investigator at the Institute for Health Research. Her research team focuses on defining, understanding, and testing interventions to improve cardiovascular health. Dr. Daugherty received her medical training at the University of Minnesota Medical School, in Minneapolis, Minnesota and completed an internship, residency, and Cardiology Fellowship at the University of Colorado School of Medicine. She also received a Master of Science in Public Health from the University of Colorado Health Sciences Center. She has led multisite pragmatic trials and observational studies focused on health disparities, social determinants of health, quality of care, and outcomes of people with cardiovascular disease. In addition to her own research portfolio, Dr. Daugherty is the medical director for the clinical trials program at Kaiser Permanente Colorado overseeing a broad portfolio of sponsor funded clinical trials across multiple clinical specialties.
Dr. Daugherty is a practicing clinical physician in Cardiology with the Colorado Permanente Medical Group at Kaiser Permanente Colorado. She is also a Professor of Medicine at the University of Colorado School of Medicine in the Division of Cardiology.
Selected Research:
- Longitudinal clinical outcomes of medically tailored meals: A retrospective cohort study in Kaiser Permanente Colorado
- Funder: Kaiser Permanente Colorado
- Award End Date: 12/30/2026
- Planning an Innovative Multisite Clinical Trial to Assess Food is Medicine for Sustained Behavior Change
- Funder: American Heart Association
- Award End Date: 06/30/2026
- Structural Conditions and Health After Release from Prison: The SCHARP study
- Funder: National Heart, Lung, and Blood Institute, NIH
- Award End Date: 06/30/2027
- Using AI text messaging technology to improve AHA's LE8 Health Behaviors: Chat 4 Heart Health
- Funder: National Heart, Lung, and Blood Institute, NIH
- Award End Date: 05/31/2028
- Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities
- Funder: National Heart, Lung, and Blood Institute, NIH
- Award End Date: 05/31/2021
We will link data from a community organization which provides medically tailored meals to KPCO clinical datasets to create a retrospective cohort to compare characteristics and clinical outcomes among KPCO members with and without medically tailored meal participation.
The overarching aim of this proposal is to develop a grant application for a multi-site, randomized trial of a Food is Medicine intervention to improve and sustain healthy eating behavior in patients with heart failure.
People released from prison suffer from poor cardiovascular health, high rates of cardiovascular mortality, and other health problems. The overall objective of this research is to examine organizational policies and practices in healthcare systems that affect people’s access to quality healthcare after release from prison, to assist healthcare systems and other organizations in addressing the health care gaps among this population.
The goal of the Chat 4 Heart Health pragmatic, patient-level randomized clinical trial is to improve control of cardiovascular risk factors by engaging patients from federally qualified health centers who have elevated cardiovascular risk with a technology-based self-management intervention focusing on control of the American Heart Association’s Life’s Essential 8 (LE8) lifestyle factors.
The objective of the Hypertension and Values (HYVALUE) multicenter trial was to use an intervention targeting stereotype threat, values affirmation, to reduce racial disparities in hypertension.